EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial

BACKGROUND: The potential interest of antifungal treatment of non-immunocompromized patients with sepsis, extra-digestive Candida colonization and multiple organ failure is unknown. It represents three-quarters of antifungals prescribed in Intensive Care Units. It may allow early treatment of invasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Timsit, Jean-François, Azoulay, Elie, Cornet, Muriel, Gangneux, Jean-Pierre, Jullien, Vincent, Vésin, Aurélien, Schir, Edith, Wolff, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222830/
https://www.ncbi.nlm.nih.gov/pubmed/24261608
http://dx.doi.org/10.1186/1745-6215-14-399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222830/
https://www.ncbi.nlm.nih.gov/pubmed/24261608
http://dx.doi.org/10.1186/1745-6215-14-399

Ejemplares similares